Schedule 13G ownership disclosure
Rich Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 76303T209
Event date: 2015-09-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-054541
- Form type
- SC 13G
- Filer
- Rich Pharmaceuticals, Inc.
- CIK
- CIK 1504389
- Filed
- Sep 11, 2015
- Reporting period
- Sep 08, 2015
- Description
- Schedule 13G beneficial ownership